Bohui Group

Bohui Group, officially Beijing Bohui Innovation Biotechnology Group Co., Ltd., is a China-based listed life sciences and biomedical company that integrates R&D, manufacturing, sales, and after-sales service across diagnostics, blood products, vaccines, and scientific instruments. The company markets in vitro diagnostic systems including microfluidic and cartridge-based nucleic acid testing platforms, nucleic acid chip analyzers, trace element testing instruments, and immunoassay systems, alongside plasma-derived products such as albumin, immunoglobulins, coagulation factors, and a human rabies vaccine. Through its ownership of Advion and combination with Interchim operations, it also participates in mass spectrometry, chromatography, purification, and related laboratory workflow tools under the Advion Interchim Scientific brand. Bohui Group appears to be primarily a commercial-stage healthcare and life science tools company rather than a therapeutics developer, with revenue-generating products and manufacturing assets in China plus international instrument operations. Its business mix spans diagnostics, biologics, vaccines, and analytical instrumentation for clinical, pharmaceutical, biotechnology, and research customers.